Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Gene Silencing
1.2.3 Gene Replacement
1.2.4 Gene Addition
1.2.5 Gene Editing
1.3 Market by Application
1.3.1 Global Adeno-Associated Virus Gene Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Research Institute
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adeno-Associated Virus Gene Therapy Market Perspective (2018-2033)
2.2 Adeno-Associated Virus Gene Therapy Growth Trends by Region
2.2.1 Global Adeno-Associated Virus Gene Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Adeno-Associated Virus Gene Therapy Historic Market Size by Region (2018-2023)
2.2.3 Adeno-Associated Virus Gene Therapy Forecasted Market Size by Region (2024-2033)
2.3 Adeno-Associated Virus Gene Therapy Market Dynamics
2.3.1 Adeno-Associated Virus Gene Therapy Industry Trends
2.3.2 Adeno-Associated Virus Gene Therapy Market Drivers
2.3.3 Adeno-Associated Virus Gene Therapy Market Challenges
2.3.4 Adeno-Associated Virus Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adeno-Associated Virus Gene Therapy Players by Revenue
3.1.1 Global Top Adeno-Associated Virus Gene Therapy Players by Revenue (2018-2023)
3.1.2 Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Adeno-Associated Virus Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adeno-Associated Virus Gene Therapy Revenue
3.4 Global Adeno-Associated Virus Gene Therapy Market Concentration Ratio
3.4.1 Global Adeno-Associated Virus Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adeno-Associated Virus Gene Therapy Revenue in 2022
3.5 Adeno-Associated Virus Gene Therapy Key Players Head office and Area Served
3.6 Key Players Adeno-Associated Virus Gene Therapy Product Solution and Service
3.7 Date of Enter into Adeno-Associated Virus Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adeno-Associated Virus Gene Therapy Breakdown Data by Type
4.1 Global Adeno-Associated Virus Gene Therapy Historic Market Size by Type (2018-2023)
4.2 Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Type (2024-2033)
5 Adeno-Associated Virus Gene Therapy Breakdown Data by Application
5.1 Global Adeno-Associated Virus Gene Therapy Historic Market Size by Application (2018-2023)
5.2 Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
6.2 North America Adeno-Associated Virus Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023)
6.4 North America Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
7.2 Europe Adeno-Associated Virus Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023)
7.4 Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
8.2 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
9.2 Latin America Adeno-Associated Virus Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023)
9.4 Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
10.2 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Detail
11.1.2 Creative Biolabs Business Overview
11.1.3 Creative Biolabs Adeno-Associated Virus Gene Therapy Introduction
11.1.4 Creative Biolabs Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.1.5 Creative Biolabs Recent Development
11.2 Affinia Therapeutics
11.2.1 Affinia Therapeutics Company Detail
11.2.2 Affinia Therapeutics Business Overview
11.2.3 Affinia Therapeutics Adeno-Associated Virus Gene Therapy Introduction
11.2.4 Affinia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.2.5 Affinia Therapeutics Recent Development
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Detail
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Adeno-Associated Virus Gene Therapy Introduction
11.3.4 Spark Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.3.5 Spark Therapeutics Recent Development
11.4 AGC Biologics
11.4.1 AGC Biologics Company Detail
11.4.2 AGC Biologics Business Overview
11.4.3 AGC Biologics Adeno-Associated Virus Gene Therapy Introduction
11.4.4 AGC Biologics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.4.5 AGC Biologics Recent Development
11.5 StrideBio
11.5.1 StrideBio Company Detail
11.5.2 StrideBio Business Overview
11.5.3 StrideBio Adeno-Associated Virus Gene Therapy Introduction
11.5.4 StrideBio Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.5.5 StrideBio Recent Development
11.6 SIRION Biotech
11.6.1 SIRION Biotech Company Detail
11.6.2 SIRION Biotech Business Overview
11.6.3 SIRION Biotech Adeno-Associated Virus Gene Therapy Introduction
11.6.4 SIRION Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.6.5 SIRION Biotech Recent Development
11.7 Neurophth Biotechnology
11.7.1 Neurophth Biotechnology Company Detail
11.7.2 Neurophth Biotechnology Business Overview
11.7.3 Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Introduction
11.7.4 Neurophth Biotechnology Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.7.5 Neurophth Biotechnology Recent Development
11.8 Belief BioMed
11.8.1 Belief BioMed Company Detail
11.8.2 Belief BioMed Business Overview
11.8.3 Belief BioMed Adeno-Associated Virus Gene Therapy Introduction
11.8.4 Belief BioMed Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.8.5 Belief BioMed Recent Development
11.9 BiBo Biopharma Engineering Co., Ltd.
11.9.1 BiBo Biopharma Engineering Co., Ltd. Company Detail
11.9.2 BiBo Biopharma Engineering Co., Ltd. Business Overview
11.9.3 BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Introduction
11.9.4 BiBo Biopharma Engineering Co., Ltd. Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.9.5 BiBo Biopharma Engineering Co., Ltd. Recent Development
11.10 Beihai Kangcheng
11.10.1 Beihai Kangcheng Company Detail
11.10.2 Beihai Kangcheng Business Overview
11.10.3 Beihai Kangcheng Adeno-Associated Virus Gene Therapy Introduction
11.10.4 Beihai Kangcheng Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.10.5 Beihai Kangcheng Recent Development
11.11 PackGene Biotech
11.11.1 PackGene Biotech Company Detail
11.11.2 PackGene Biotech Business Overview
11.11.3 PackGene Biotech Adeno-Associated Virus Gene Therapy Introduction
11.11.4 PackGene Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.11.5 PackGene Biotech Recent Development
11.12 Sarepta Therapeutics
11.12.1 Sarepta Therapeutics Company Detail
11.12.2 Sarepta Therapeutics Business Overview
11.12.3 Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Introduction
11.12.4 Sarepta Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.12.5 Sarepta Therapeutics Recent Development
11.13 Carbon BioSciences
11.13.1 Carbon BioSciences Company Detail
11.13.2 Carbon BioSciences Business Overview
11.13.3 Carbon BioSciences Adeno-Associated Virus Gene Therapy Introduction
11.13.4 Carbon BioSciences Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.13.5 Carbon BioSciences Recent Development
11.14 Kelonia Therapeutics
11.14.1 Kelonia Therapeutics Company Detail
11.14.2 Kelonia Therapeutics Business Overview
11.14.3 Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Introduction
11.14.4 Kelonia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.14.5 Kelonia Therapeutics Recent Development
11.15 Roche
11.15.1 Roche Company Detail
11.15.2 Roche Business Overview
11.15.3 Roche Adeno-Associated Virus Gene Therapy Introduction
11.15.4 Roche Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.15.5 Roche Recent Development
11.16 Remedium Bio
11.16.1 Remedium Bio Company Detail
11.16.2 Remedium Bio Business Overview
11.16.3 Remedium Bio Adeno-Associated Virus Gene Therapy Introduction
11.16.4 Remedium Bio Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.16.5 Remedium Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Gene Silencing
Table 3. Key Players of Gene Replacement
Table 4. Key Players of Gene Addition
Table 5. Key Players of Gene Editing
Table 6. Global Adeno-Associated Virus Gene Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Adeno-Associated Virus Gene Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Adeno-Associated Virus Gene Therapy Market Share by Region (2018-2023)
Table 10. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Adeno-Associated Virus Gene Therapy Market Share by Region (2024-2033)
Table 12. Adeno-Associated Virus Gene Therapy Market Trends
Table 13. Adeno-Associated Virus Gene Therapy Market Drivers
Table 14. Adeno-Associated Virus Gene Therapy Market Challenges
Table 15. Adeno-Associated Virus Gene Therapy Market Restraints
Table 16. Global Adeno-Associated Virus Gene Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Adeno-Associated Virus Gene Therapy Market Share by Players (2018-2023)
Table 18. Global Top Adeno-Associated Virus Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus Gene Therapy as of 2022)
Table 19. Ranking of Global Top Adeno-Associated Virus Gene Therapy Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Adeno-Associated Virus Gene Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Adeno-Associated Virus Gene Therapy Product Solution and Service
Table 23. Date of Enter into Adeno-Associated Virus Gene Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2018-2023)
Table 27. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2024-2033)
Table 29. Global Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Application (2018-2023)
Table 31. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Application (2024-2033)
Table 33. North America Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 48. Creative Biolabs Company Detail
Table 49. Creative Biolabs Business Overview
Table 50. Creative Biolabs Adeno-Associated Virus Gene Therapy Product
Table 51. Creative Biolabs Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 52. Creative Biolabs Recent Development
Table 53. Affinia Therapeutics Company Detail
Table 54. Affinia Therapeutics Business Overview
Table 55. Affinia Therapeutics Adeno-Associated Virus Gene Therapy Product
Table 56. Affinia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 57. Affinia Therapeutics Recent Development
Table 58. Spark Therapeutics Company Detail
Table 59. Spark Therapeutics Business Overview
Table 60. Spark Therapeutics Adeno-Associated Virus Gene Therapy Product
Table 61. Spark Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 62. Spark Therapeutics Recent Development
Table 63. AGC Biologics Company Detail
Table 64. AGC Biologics Business Overview
Table 65. AGC Biologics Adeno-Associated Virus Gene Therapy Product
Table 66. AGC Biologics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 67. AGC Biologics Recent Development
Table 68. StrideBio Company Detail
Table 69. StrideBio Business Overview
Table 70. StrideBio Adeno-Associated Virus Gene Therapy Product
Table 71. StrideBio Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 72. StrideBio Recent Development
Table 73. SIRION Biotech Company Detail
Table 74. SIRION Biotech Business Overview
Table 75. SIRION Biotech Adeno-Associated Virus Gene Therapy Product
Table 76. SIRION Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 77. SIRION Biotech Recent Development
Table 78. Neurophth Biotechnology Company Detail
Table 79. Neurophth Biotechnology Business Overview
Table 80. Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Product
Table 81. Neurophth Biotechnology Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 82. Neurophth Biotechnology Recent Development
Table 83. Belief BioMed Company Detail
Table 84. Belief BioMed Business Overview
Table 85. Belief BioMed Adeno-Associated Virus Gene Therapy Product
Table 86. Belief BioMed Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 87. Belief BioMed Recent Development
Table 88. BiBo Biopharma Engineering Co., Ltd. Company Detail
Table 89. BiBo Biopharma Engineering Co., Ltd. Business Overview
Table 90. BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Product
Table 91. BiBo Biopharma Engineering Co., Ltd. Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 92. BiBo Biopharma Engineering Co., Ltd. Recent Development
Table 93. Beihai Kangcheng Company Detail
Table 94. Beihai Kangcheng Business Overview
Table 95. Beihai Kangcheng Adeno-Associated Virus Gene Therapy Product
Table 96. Beihai Kangcheng Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 97. Beihai Kangcheng Recent Development
Table 98. PackGene Biotech Company Detail
Table 99. PackGene Biotech Business Overview
Table 100. PackGene Biotech Adeno-Associated Virus Gene Therapy Product
Table 101. PackGene Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 102. PackGene Biotech Recent Development
Table 103. Sarepta Therapeutics Company Detail
Table 104. Sarepta Therapeutics Business Overview
Table 105. Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Product
Table 106. Sarepta Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 107. Sarepta Therapeutics Recent Development
Table 108. Carbon BioSciences Company Detail
Table 109. Carbon BioSciences Business Overview
Table 110. Carbon BioSciences Adeno-Associated Virus Gene Therapy Product
Table 111. Carbon BioSciences Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 112. Carbon BioSciences Recent Development
Table 113. Kelonia Therapeutics Company Detail
Table 114. Kelonia Therapeutics Business Overview
Table 115. Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Product
Table 116. Kelonia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 117. Kelonia Therapeutics Recent Development
Table 118. Roche Company Detail
Table 119. Roche Business Overview
Table 120. Roche Adeno-Associated Virus Gene Therapy Product
Table 121. Roche Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 122. Roche Recent Development
Table 123. Remedium Bio Company Detail
Table 124. Remedium Bio Business Overview
Table 125. Remedium Bio Adeno-Associated Virus Gene Therapy Product
Table 126. Remedium Bio Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 127. Remedium Bio Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adeno-Associated Virus Gene Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Adeno-Associated Virus Gene Therapy Market Share by Type: 2022 VS 2033
Figure 3. Gene Silencing Features
Figure 4. Gene Replacement Features
Figure 5. Gene Addition Features
Figure 6. Gene Editing Features
Figure 7. Global Adeno-Associated Virus Gene Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Adeno-Associated Virus Gene Therapy Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Research Institute Case Studies
Figure 11. Others Case Studies
Figure 12. Adeno-Associated Virus Gene Therapy Report Years Considered
Figure 13. Global Adeno-Associated Virus Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Adeno-Associated Virus Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Adeno-Associated Virus Gene Therapy Market Share by Region: 2022 VS 2033
Figure 16. Global Adeno-Associated Virus Gene Therapy Market Share by Players in 2022
Figure 17. Global Top Adeno-Associated Virus Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus Gene Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Adeno-Associated Virus Gene Therapy Revenue in 2022
Figure 19. North America Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Adeno-Associated Virus Gene Therapy Market Share by Country (2018-2033)
Figure 21. United States Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Adeno-Associated Virus Gene Therapy Market Share by Country (2018-2033)
Figure 25. Germany Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Share by Region (2018-2033)
Figure 33. China Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Adeno-Associated Virus Gene Therapy Market Share by Country (2018-2033)
Figure 41. Mexico Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Share by Country (2018-2033)
Figure 45. Turkey Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Creative Biolabs Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 48. Affinia Therapeutics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 49. Spark Therapeutics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 50. AGC Biologics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 51. StrideBio Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 52. SIRION Biotech Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 53. Neurophth Biotechnology Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 54. Belief BioMed Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 55. BiBo Biopharma Engineering Co., Ltd. Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 56. Beihai Kangcheng Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 57. PackGene Biotech Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 58. Sarepta Therapeutics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 59. Carbon BioSciences Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 60. Kelonia Therapeutics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 61. Roche Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 62. Remedium Bio Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed